Israel Englander Aclaris Therapeutics, Inc. Transaction History

Millennium Management LLC

$192 Billion
Q2 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 3,837,380 shares of ACRS stock, worth $6.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,837,380

Previous 4,134,148 7.18%

Holding current value

$6.29 Million

Previous $6.33 Million 13.85%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$1.08 - $1.63 $320,509 - $483,731	-296,768 Reduced 7.18%	3,837,380 $5.45 Million
Q1 2025 May 15, 2025	BUY	$1.53 - $2.6 $3.33 Million - $5.66 Million	2,175,101 Added 111.03%	4,134,148 $6.33 Million
Q4 2024 Feb 14, 2025	SELL	$1.15 - $4.59 $1.2 Million - $4.8 Million	-1,046,551 Reduced 34.82%	1,959,047 $4.86 Million
Q3 2024 Nov 14, 2024	SELL	$1.12 - $1.4 $371,002 - $463,752	-331,252 Reduced 9.93%	3,005,598 $3.4 Million
Q2 2024 Aug 14, 2024	BUY	$1.01 - $1.36 $63,991 - $86,166	63,358 Added 1.94%	3,336,850 $3.67 Million
Q1 2024 May 15, 2024	SELL	$0.92 - $1.44 $189,399 - $296,451	-205,869 Reduced 5.92%	3,273,492 $4.06 Million
Q4 2023 Feb 14, 2024	BUY	$0.64 - $6.49 $1.7 Million - $17.2 Million	2,652,277 Added 320.68%	3,479,361 $3.65 Million
Q2 2023 Aug 14, 2023	BUY	$7.89 - $10.64 $6.05 Million - $8.15 Million	766,221 Added 1258.93%	827,084 $8.58 Million
Q1 2023 May 15, 2023	SELL	$7.07 - $17.95 $1.04 Million - $2.64 Million	-147,035 Reduced 70.72%	60,863 $492,000
Q4 2022 Feb 14, 2023	BUY	$14.33 - $18.37 $57,219 - $73,351	3,993 Added 1.96%	207,898 $3.27 Million
Q3 2022 Nov 14, 2022	BUY	$13.07 - $18.22 $66,800 - $93,122	5,111 Added 2.57%	203,905 $3.21 Million
Q2 2022 Aug 15, 2022	BUY	$10.16 - $17.08 $1.45 Million - $2.44 Million	142,581 Added 253.64%	198,794 $2.78 Million
Q1 2022 May 16, 2022	SELL	$9.74 - $17.92 $2.89 Million - $5.31 Million	-296,294 Reduced 84.05%	56,213 $969,000
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.49 $384,247 - $579,032	31,316 Added 9.75%	352,507 $5.13 Million
Q3 2021 Nov 15, 2021	BUY	$13.38 - $18.8 $1.62 Million - $2.27 Million	120,827 Added 60.3%	321,191 $5.78 Million
Q2 2021 Aug 16, 2021	SELL	$17.08 - $29.6 $2.44 Million - $4.23 Million	-142,883 Reduced 41.63%	200,364 $3.52 Million
Q1 2021 May 17, 2021	BUY	$5.86 - $27.73 $787,121 - $3.72 Million	134,321 Added 64.29%	343,247 $8.65 Million
Q4 2020 Feb 16, 2021	SELL	$2.65 - $7.61 $193,110 - $554,555	-72,872 Reduced 25.86%	208,926 $1.35 Million
Q3 2020 Nov 16, 2020	SELL	$1.5 - $2.71 $154,705 - $279,501	-103,137 Reduced 26.79%	281,798 $724,000
Q2 2020 Aug 14, 2020	BUY	$1.04 - $1.73 $400,332 - $665,937	384,935 New	384,935 $624,000
Q1 2020 May 14, 2020	SELL	$0.75 - $2.18 $211,386 - $614,428	-281,848 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.02 - $1.97 $21,824 - $42,152	21,397 Added 8.22%	281,848 $533,000
Q3 2019 Nov 14, 2019	BUY	$0.79 - $2.47 $177,801 - $555,910	225,065 Added 636.03%	260,451 $281,000
Q2 2019 Aug 15, 2019	SELL	$2.13 - $7.06 $264,618 - $877,092	-124,234 Reduced 77.83%	35,386 $77,000
Q2 2019 Aug 14, 2019	BUY	$2.13 - $7.06 $295,469 - $979,349	138,718 Added 663.66%	159,620 $5.3 Million
Q1 2019 May 14, 2019	BUY	$5.63 - $7.84 $117,678 - $163,871	20,902 New	20,902 $125,000
Q2 2018 Aug 14, 2018	SELL	$16.46 - $20.33 $1.82 Million - $2.25 Million	-110,827 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$17.08 - $25.64 $1.69 Million - $2.54 Million	99,029 Added 839.37%	110,827 $1.94 Million
Q4 2017 Feb 14, 2018	BUY	$21.47 - $27.8 $253,303 - $327,984	11,798	11,798 $291,000

Others Institutions Holding ACRS

# of Institutions

Shares Held

87.7M

Call Options Held

Put Options Held

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $109M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account